243 related articles for article (PubMed ID: 9168925)
41. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
Lund OS; Nielsen JO; Hansen JE
Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
[TBL] [Abstract][Full Text] [Related]
42. Phosphorothioate G3T4G3 motifs inhibits the early stage of HIV-1 infection.
Suzuki J; Miyano-Kurosaki N; Takeuchi H; Tamura Y; Kawai G; Takai K; Tanaka Y; Tanaka R; Yamamoto N; Takaku H
Nucleic Acids Symp Ser; 1999; (42):227-8. PubMed ID: 10780462
[TBL] [Abstract][Full Text] [Related]
43. The HIV plus-strand transfer reaction: determination of replication-competent intermediates and identification of a novel lentiviral element, the primer over-extension sequence.
Muthuswami R; Chen J; Burnett BP; Thimmig RL; Janjic N; McHenry CS
J Mol Biol; 2002 Jan; 315(3):311-23. PubMed ID: 11786014
[TBL] [Abstract][Full Text] [Related]
44. Cellular antisense activity of peptide nucleic acid (PNAs) targeted to HIV-1 polypurine tract (PPT) containing RNA.
Boutimah-Hamoudi F; Leforestier E; Sénamaud-Beaufort C; Nielsen PE; Giovannangeli C; Saison-Behmoaras TE
Nucleic Acids Res; 2007; 35(12):3907-17. PubMed ID: 17537815
[TBL] [Abstract][Full Text] [Related]
45. Variant effects of non-native kissing-loop hairpin palindromes on HIV replication and HIV RNA dimerization: role of stem-loop B in HIV replication and HIV RNA dimerization.
Laughrea M; Shen N; Jetté L; Wainberg MA
Biochemistry; 1999 Jan; 38(1):226-34. PubMed ID: 9890902
[TBL] [Abstract][Full Text] [Related]
46. Oligonucleotides as inhibitors of human immunodeficiency virus.
Field AK
Curr Opin Mol Ther; 1999 Jun; 1(3):323-31. PubMed ID: 11713797
[TBL] [Abstract][Full Text] [Related]
47. Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity.
Tang JY; Temsamani J; Agrawal S
Nucleic Acids Res; 1993 Jun; 21(11):2729-35. PubMed ID: 8392706
[TBL] [Abstract][Full Text] [Related]
48. Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies.
Agrawal S; Jiang Z; Zhao Q; Shaw D; Cai Q; Roskey A; Channavajjala L; Saxinger C; Zhang R
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2620-5. PubMed ID: 9122245
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of influenza virus RNA polymerase and nucleoprotein of gene expression by antisense oligonucleotides.
Hatta T; Nakagawa Y; Takai K; Nakada S; Yokota T; Takaku H
Nucleic Acids Symp Ser; 1995; (34):129-30. PubMed ID: 8841586
[TBL] [Abstract][Full Text] [Related]
50. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by unmodified, phosphorothioated, and liposomally encapsulated oligonucleotides.
Hatta T; Nakagawa Y; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1996 Jun; 223(2):341-6. PubMed ID: 8670284
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of replication initiation by triple helix-forming oligonucleotides.
Guieysse AL; Praseuth D; Francois JC; Helene C
Biochem Biophys Res Commun; 1995 Dec; 217(1):186-94. PubMed ID: 8526909
[TBL] [Abstract][Full Text] [Related]
53. Glucose conjugation of anti-HIV-1 oligonucleotides containing unmethylated CpG motifs reduces their immunostimulatory activity.
Reyes-Darias JA; Sánchez-Luque FJ; Morales JC; Pérez-Rentero S; Eritja R; Berzal-Herranz A
Chembiochem; 2015 Mar; 16(4):584-91. PubMed ID: 25683851
[TBL] [Abstract][Full Text] [Related]
54. Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells.
Barnor JS; Miyano-Kurosaki N; Yamaguchi K; Sakamoto A; Ishikawa K; Inagaki Y; Yamamoto N; Osei-Kwasi M; Ofori-Adjei D; Takaku H
Biochem Biophys Res Commun; 2004 Jul; 320(2):544-50. PubMed ID: 15219863
[TBL] [Abstract][Full Text] [Related]
55. Elucidation of gene function using C-5 propyne antisense oligonucleotides.
Flanagan WM; Su LL; Wagner RW
Nat Biotechnol; 1996 Sep; 14(9):1139-45. PubMed ID: 9631067
[TBL] [Abstract][Full Text] [Related]
56. Identification of sequences in rotavirus mRNAs important for minus strand synthesis using antisense oligonucleotides.
Barro M; Mandiola P; Chen D; Patton JT; Spencer E
Virology; 2001 Sep; 288(1):71-80. PubMed ID: 11543659
[TBL] [Abstract][Full Text] [Related]
57. A quantitative assay for HIV DNA integration in vivo.
Butler SL; Hansen MS; Bushman FD
Nat Med; 2001 May; 7(5):631-4. PubMed ID: 11329067
[TBL] [Abstract][Full Text] [Related]
58. Use of modified U1 snRNAs to inhibit HIV-1 replication.
Sajic R; Lee K; Asai K; Sakac D; Branch DR; Upton C; Cochrane A
Nucleic Acids Res; 2007; 35(1):247-55. PubMed ID: 17158512
[TBL] [Abstract][Full Text] [Related]
59. [In vitro anti-HIV activity of phosphorothioate alpha-anomeric oligodeoxynucleotides].
Rayner B; Matsukura M; Morvan F; Cohen JS; Imbach JL
C R Acad Sci III; 1989; 310(3):61-4. PubMed ID: 2516764
[TBL] [Abstract][Full Text] [Related]
60. Efficient inhibition of HIV-1 expression by LNA modified antisense oligonucleotides and DNAzymes targeted to functionally selected binding sites.
Jakobsen MR; Haasnoot J; Wengel J; Berkhout B; Kjems J
Retrovirology; 2007 Apr; 4():29. PubMed ID: 17459171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
